>
Clearpoint Neuro Inc logo

CLPT - Clearpoint Neuro Inc Share Price

$18 0.5  3.0%

Last Trade - 8:05pm

Sector
Healthcare
Size
Small Cap
Market Cap £259.3m
Enterprise Value £260.1m
Revenue £9.21m
Position in Universe 3878th / 6852
Bullish
Bearish
Unlock CLPT Revenue
Momentum
Relative Strength (%)
1m -17.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -44.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
4.59 5.75 7.38 7.35 11.2 12.8 15.8 25.2 +22.8%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020,Clearpoint Neuro Inc revenues increased 14% to $12.8M. Netloss increased 22% to $6.8M. Revenues reflect Services:Biologics and drug delivery segment increase from $890K to$3.6M, Services: Capital equipment and other segmentincrease of 68% to $1.1M. Higher net loss reflects Researchand development costs increase of 60% to $4.7M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for CLPT
Graphical History

Revenue

CLPT Revenue Unlock CLPT Revenue

Net Income

CLPT Net Income Unlock CLPT Revenue

Normalised EPS

CLPT Normalised EPS Unlock CLPT Revenue

PE Ratio Range

CLPT PE Ratio Range Unlock CLPT Revenue

Dividend Yield Range

CLPT Dividend Yield Range Unlock CLPT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
CLPT EPS Forecasts Unlock CLPT Revenue
Profile Summary

Clearpoint Neuro Inc, formerly MRI Interventions, Inc., MRI Interventions, Inc. is a medical device company. The Company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. It has two product platforms: ClearPoint system, which is used to perform minimally invasive surgical procedures in the brain and ClearTrace system, which is under development, to be used to perform minimally invasive surgical procedures in the heart. Its ClearPoint system is a neuro-navigation system designed for placing catheters and electrodes to treat a range of neurological diseases and conditions and for performing biopsies. Its ClearTrace system is designed to deliver catheter-based therapies to treat certain cardiac diseases. Both systems utilize intra-procedural MRI to guide the procedures.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated March 12, 1998
Public Since July 3, 2019
No. of Shareholders: 210
No. of Employees: 67
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 20,672,779
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CLPT Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CLPT
Upcoming Events for CLPT
Monday 10th May, 2021 Estimate
Q1 2021 Clearpoint Neuro Inc Earnings Release
Thursday 3rd June, 2021
Clearpoint Neuro Inc Annual Shareholders Meeting
Wednesday 2nd June, 2021 Estimate
Clearpoint Neuro Inc Annual Shareholders Meeting
Tuesday 10th August, 2021 Estimate
Q2 2021 Clearpoint Neuro Inc Earnings Release
Frequently Asked Questions for Clearpoint Neuro Inc
What is the Clearpoint Neuro Inc share price?

As of 8:05pm, shares in Clearpoint Neuro Inc are trading at $18, giving the company a market capitalisation of £259.3m. This share price information is delayed by 15 minutes.

How has the Clearpoint Neuro Inc share price performed this year?

Shares in Clearpoint Neuro Inc are currently trading at $18 and the price has moved by 0.369k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Clearpoint Neuro Inc price has moved by 0.208k% over the past year.

What are the analyst and broker recommendations for Clearpoint Neuro Inc?

Of the analysts with advisory recommendations for Clearpoint Neuro Inc, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Clearpoint Neuro Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Clearpoint Neuro Inc next release its financial results?

Clearpoint Neuro Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Clearpoint Neuro Inc dividend yield?

Clearpoint Neuro Inc does not currently pay a dividend.

Does Clearpoint Neuro Inc pay a dividend?

Clearpoint Neuro Inc does not currently pay a dividend.

When does Clearpoint Neuro Inc next pay dividends?

Clearpoint Neuro Inc does not currently pay a dividend.

How do I buy Clearpoint Neuro Inc shares?

To buy shares in Clearpoint Neuro Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Clearpoint Neuro Inc?

Shares in Clearpoint Neuro Inc are currently trading at $18, giving the company a market capitalisation of £259.3m.

Where are Clearpoint Neuro Inc shares listed? Where are Clearpoint Neuro Inc shares listed?

Here are the trading details for Clearpoint Neuro Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: CLPT
What kind of share is Clearpoint Neuro Inc?

Based on an overall assessment of its quality, value and momentum, Clearpoint Neuro Inc is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Clearpoint Neuro Inc share price forecast 2021?

Shares in Clearpoint Neuro Inc are currently priced at $18. At that level they are trading at 0.1% discount to the analyst consensus target price of 0.00.

Analysts covering Clearpoint Neuro Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.5 for the next financial year.

How can I tell whether the Clearpoint Neuro Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Clearpoint Neuro Inc. Over the past six months, the relative strength of its shares against the market has been 99.31%. At the current price of $18, shares in Clearpoint Neuro Inc are trading at 44.34% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Clearpoint Neuro Inc PE Ratio?

We were not able to find PE ratio data for Clearpoint Neuro Inc.

Who are the key directors of Clearpoint Neuro Inc?

Clearpoint Neuro Inc's management team is headed by:

Peter Piferi - COO
Timothy Richards - IND
Pascal Girin - IND
R. John Fletcher - CHM
Joseph Burnett - PRE
B. Kristine Johnson - IND
Matthew Klein - IND
Marcio Souza - IND
Danilo D Alessandro - CFO
Ellisa Cholapranee - GCN
Who are the major shareholders of Clearpoint Neuro Inc?

Here are the top five shareholders of Clearpoint Neuro Inc based on the size of their shareholding:

PTC Therapeutics Inc Corporation
Percentage owned: 6.31% (1.29m shares)
Conway (Bruce C) Individual Investor
Percentage owned: 5.24% (1.08m shares)
Peierls (E Jeffrey) Individual Investor
Percentage owned: 3.37% (691k shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 2.9% (595k shares)
Parian Global Management LP Hedge Fund
Percentage owned: 2.26% (463k shares)
Similar to CLPT
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.